David Perdue sold Pfizer Inc (NYSE: PFE)
David Perdue sold PFE · disclosed May 4, 2018
David Perdue, a GA Senate member representing District N/A, sold $1,001 - $15,000 of Pfizer Inc (PFE) on January 13, 2016. Filings associated with David Perdue disclosed 5 other PFE transactions (5 sales) in the 12 months before this trade. Shares of PFE have risen 29.0% since the first observed purchase on February 6, 2017. The filing was publicly disclosed on May 4, 2018; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For David Perdue's complete filing history, visit David Perdue's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on PFE break down as 0 strong buy, 6 buy, 8 neutral, 1 sell, 0 strong sell.
- PFE carries a Risk Score of 99 as of November 20, 2026. On this scale, a higher score means a lower risk surface.
- David Perdue sold PFE in the amount range of $1,001 - $15,000 on January 13, 2016, filed under the STOCK Act.
- The filing lists Joint as the transaction owner and was disclosed n/a after the trade.
- The asset description in the filing reads 'Pfizer Inc..'
- Filings associated with David Perdue disclosed 5 other PFE transactions (5 sales) in the 12 months before this trade.
- Shares of PFE have risen 29.0% since the first observed purchase on February 6, 2017.
- PFE carried a Q Score of 0 in its equity peer group as of date unavailable.
- PFE carried a Squeeze Score of 22 as of November 21, 2026.
Did David Perdue buy or sell PFE?
The Periodic Transaction Report covers a single sale involving PFE on January 13, 2016. The filed amount range is $1,001 - $15,000. The asset description reads 'Pfizer Inc.', as submitted by the filer. The report was submitted on May 4, 2018. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| David Perdue (Senate) | Sell | PFE | $1,001 - $15,000 | January 13, 2016 | May 4, 2018 |
What other PFE trades has David Perdue disclosed in the past 12 months?
Filings associated with David Perdue disclosed 5 other PFE transactions (5 sales) in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| May 14, 2015 | Sell | Joint | $1,001 - $15,000 | Filing unavailable |
| May 7, 2015 | Sell | Joint | $1,001 - $15,000 | Filing unavailable |
| May 6, 2015 | Sell | Joint | $1,001 - $15,000 | Filing unavailable |
| May 6, 2015 | Sell | Joint | $1,001 - $15,000 | Filing unavailable |
| April 29, 2015 | Sell | Joint | $1,001 - $15,000 | Filing unavailable |
What does the filing show, and what does it not show?
The filing reports a sale involving PFE by David Perdue in the amount range of $1,001 - $15,000, with Joint listed as the owner. It does not establish David Perdue's total holdings in PFE, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Pfizer Inc.', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify David Perdue's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with David Perdue disclosed 5 other PFE transactions (5 sales) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded PFE?
Quantellect's current database lists these recent PFE disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| Rohit Khanna Spouse | D House | Buy | $15,001 - $50,000 | November 5, 2026Filing unavailable |
| Rohit Khanna Spouse | D House | Buy | $1,001 - $15,000 | October 7, 2026Filing unavailable |
| Rohit Khanna Dependent child | D House | Buy | $1,001 - $15,000 | October 7, 2026Filing unavailable |
| Rohit Khanna Spouse | D House | Sell | $15,001 - $50,000 | October 7, 2026Filing unavailable |
| Rohit Khanna Dependent child | D House | Buy | $1,001 - $15,000 | August 7, 2026Filing unavailable |
How has David Perdue's disclosed trading performed?
A current measured Member Score is not available for this member. Quantellect does not infer performance where the scored-trade projection lacks coverage.
All David Perdue PFE trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did David Perdue buy or sell PFE?
According to the disclosure, David Perdue sold PFE on January 13, 2016.
What amount was reported for the PFE transaction?
The disclosure reports $1,001 - $15,000 for the sale. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated January 13, 2016, and it was disclosed on May 4, 2018.
Where can I see David Perdue's other congressional trades?
Quantellect lists David Perdue's complete disclosed trade history on the member profile. David Perdue's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.

